Cargando…
631. Preliminary safety and pharmacokinetic profile of VIR-2482: a monoclonal antibody for the prevention of influenza A illness
BACKGROUND: VIR-2482 is a fully human immunoglobulin G1(IgG) monoclonal antibody (mAb) directed against a highly-conserved epitope in the influenza A hemagglutinin stem region and is in clinical development for the prevention of influenza A illness. The Fc region of VIR-2482 has been modified to pro...
Autores principales: | Sager, Jennifer, Hong, David K, Bonavia, Aurelio, Connolly, Lynn, Cebrik, Deborah, Fanget, Marie Christine, Mogalian, Erik, Griffin, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776649/ http://dx.doi.org/10.1093/ofid/ofaa439.825 |
Ejemplares similares
-
1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
por: Pizzuto, Matteo Samuele, et al.
Publicado: (2020) -
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
por: Gupta, Sneha V., et al.
Publicado: (2021) -
2482 Reward-based learning as a function of the severity of substance abuse risk in drug-naïve youth
por: Parvaz, Muhammad A., et al.
Publicado: (2018) -
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
por: Connolly, Lynn E., et al.
Publicado: (2018) -
2482. Cross Validation of Surgical Procedure Data in National Healthcare Safety Network vs Hospital Discharge Data
por: Sato, Yoran (Lana), et al.
Publicado: (2023)